Thus, understanding the immunosuppressive strategies employed by AML cells against CD8+ T cells and evaluating the interplay between tumor antigens within AML cells and TCR recognition is pivotal to the research on AML immune evasion and identification. The gene discussed is CD8A; the disease is neoplasm.